The World Health Organization calculates that up to 10% of worldwide traded drugs are fake.
WHO describes forged drugs as "those which are deliberately and fraudulently produced and/or mislabeled with respect to identity and/or source".
In September 2009, a 29-year-old University of Maryland pharmacologist succumbed to death subsequent to an allergic reaction to an imitation version of a drug, which was lawful in the United States, but had been bought online from the Philippines.
Pharmaceutical counterfeits influence persons and industry all over the society, and not just victims at the end of the supply chain.
The Federal Drug Administration has launched offices in India and China in an endeavor to watch more closely the rising numbers of pharmaceutical producers in those nations.
The truth remains that users continue to make buys beyond the safe supply chains, lured by the accessibility of hard-to-find drugs and gray-market pricing.
These customers can be voyagers refilling their medicine cupboards, whilst on holiday or simply Internet purchasers expecting to get heavy discounts on costly drugs.
In 2007, the FDA looked at almost 4,000 packages at airports in New York, Miami and Los Angeles and discovered that 85% of drugs ordered from what shoppers originally thought were Canadian pharmacies, in fact came from 27 other nations.
Unsurprisingly, a huge number of the products were also forged.